Debt-to-equity in % of RetinalGenix Technologies Inc. from Q2 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
RetinalGenix Technologies Inc. quarterly Debt-to-equity history and change rate from Q2 2022 to Q3 2025.
  • RetinalGenix Technologies Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -101 %, a 2.77% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

RetinalGenix Technologies Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -101 +2.86 +2.77% 30 Sep 2025
Q2 2025 -102 +0.59 +0.58% 30 Jun 2025
Q1 2025 -103 -2.06 -2.04% 31 Mar 2025
Q4 2024 -104 -3.46 -3.45% 31 Dec 2024
Q3 2024 -103 -3.25 -3.24% 30 Sep 2024
Q2 2024 -102 -2.11 -2.11% 30 Jun 2024
Q1 2024 -101 -0.64 -0.64% 31 Mar 2024
Q4 2023 -100 +0.02 +0.02% 31 Dec 2023
Q3 2023 -100 +0.2 +0.2% 30 Sep 2023
Q2 2023 -100 +1.68 +1.65% 30 Jun 2023
Q1 2023 -100 31 Mar 2023
Q4 2022 -100 31 Dec 2022
Q3 2022 -100 30 Sep 2022
Q2 2022 -102 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.